MARTELL RON 4
4 · Jasper Therapeutics, Inc. · Filed Oct 13, 2022
Insider Transaction Report
Form 4
MARTELL RON
DirectorPresident, CEO and Director
Transactions
- Award
Voting Common Stock
2022-10-12+506,250→ 506,250 total
Footnotes (1)
- [F1]The reported securities are represented by restricted stock units, 1/2 of which shall vest on each of April 12, 2023 and October 12, 2023, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.